[238 Pages Report] Emerging applications of microneedle drug delivery systems are expected to fuel their demand over the next decade. According to a recent report published by Future Market Insights (FMI), the global microneedle drug delivery systems market will grow at a CAGR of 6.6% between 2020 and 2030. The mark.
The global Migraine Treatment Market is predicted to generate a market value of US$ 3.2 billion in 2023 and a market value of US$ 4.74 billion by 2033, with a CAGR of 4% from 2023 to 2033. In the historical period 2018 to 2022, the Migraine Therapy market grew at a CAGR of 3%.The condition is characterized by severe.
/PRNewswire/ Renibus Therapeutics, Inc., ("Renibus"), a clinical-stage biotechnology company developing breakthrough products for cardiorenal diseases,.